- Home
- CNC vs WAT Comparison
CNC vs WAT Comparison
Compare CNC & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNC | WAT |
|---|---|---|
| Founded | 1984 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5B | 33.5B |
| IPO Year | 2001 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CNC | WAT |
|---|---|---|
| Price | $63.39 | $374.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 17 |
| Target Price | $46.75 | ★ $379.19 |
| AVG Volume (30 Days) | ★ 2.9M | 810.8K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 0.47 |
| EPS | ★ 3.11 | N/A |
| Revenue | ★ $194,777,000,000.00 | N/A |
| Revenue This Year | $8.31 | $104.66 |
| Revenue Next Year | $1.05 | $10.40 |
| P/E Ratio | $20.49 | ★ N/A |
| Revenue Growth | ★ 19.44 | N/A |
| 52 Week Low | $25.08 | $275.05 |
| 52 Week High | $69.36 | $414.15 |
Technical Indicators
Market Signals| Indicator | CNC | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 45.36 | 52.94 |
| Support Level | $63.20 | $372.18 |
| Resistance Level | $69.32 | $387.61 |
| Average True Range (ATR) | 2.24 | 11.10 |
| MACD | -0.68 | -0.72 |
| Stochastic Oscillator | 5.54 | 64.84 |
Price Performance
Historical ComparisonAbout CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
About WAT Waters Corporation
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.